全文获取类型
收费全文 | 2939篇 |
免费 | 159篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 64篇 |
儿科学 | 90篇 |
妇产科学 | 28篇 |
基础医学 | 452篇 |
口腔科学 | 83篇 |
临床医学 | 259篇 |
内科学 | 445篇 |
皮肤病学 | 127篇 |
神经病学 | 249篇 |
特种医学 | 276篇 |
外科学 | 403篇 |
综合类 | 55篇 |
预防医学 | 122篇 |
眼科学 | 43篇 |
药学 | 138篇 |
中国医学 | 7篇 |
肿瘤学 | 277篇 |
出版年
2023年 | 21篇 |
2022年 | 23篇 |
2021年 | 42篇 |
2020年 | 25篇 |
2019年 | 48篇 |
2018年 | 41篇 |
2017年 | 41篇 |
2016年 | 60篇 |
2015年 | 102篇 |
2014年 | 90篇 |
2013年 | 121篇 |
2012年 | 133篇 |
2011年 | 138篇 |
2010年 | 107篇 |
2009年 | 97篇 |
2008年 | 134篇 |
2007年 | 122篇 |
2006年 | 97篇 |
2005年 | 129篇 |
2004年 | 113篇 |
2003年 | 105篇 |
2002年 | 115篇 |
2001年 | 77篇 |
2000年 | 76篇 |
1999年 | 80篇 |
1998年 | 52篇 |
1997年 | 64篇 |
1996年 | 58篇 |
1995年 | 47篇 |
1994年 | 35篇 |
1993年 | 29篇 |
1992年 | 30篇 |
1991年 | 41篇 |
1990年 | 48篇 |
1989年 | 56篇 |
1988年 | 46篇 |
1987年 | 36篇 |
1986年 | 41篇 |
1985年 | 25篇 |
1984年 | 33篇 |
1983年 | 22篇 |
1982年 | 18篇 |
1980年 | 13篇 |
1979年 | 16篇 |
1978年 | 14篇 |
1977年 | 14篇 |
1976年 | 14篇 |
1975年 | 16篇 |
1970年 | 13篇 |
1969年 | 18篇 |
排序方式: 共有3118条查询结果,搜索用时 15 毫秒
91.
92.
Martin F. Sprinzl Arndt Weinmann Nikola Lohse Hanna Tönissen Sandra Koch Jörn Schattenberg Maria Hoppe‐Lotichius Tim Zimmermann Peter R. Galle Torsten Hansen Gerd Otto Marcus Schuchmann 《Transplant international》2013,26(1):67-74
The metabolic syndrome (MetS) might contribute to morbidity after orthotopic liver transplantation (OLT). For this reason, we searched for MetS‐associated risk factors and analyzed the link with nonalcoholic fatty liver disease (NAFLD) in OLT recipients. De novo MetS affected 32.9% of our cohort (n = 170) within 2 years after OLT. Multivariate analysis identified glycosylated hemoglobin (HbA1c) levels ≥5% [odds ratio (OR) = 3.5; 95% confidence interval (CI) = 1.56–8.13, P = 0.003], diabetes mellitus (OR = 4.31, CI = 1.69–10.99, P = 0.002), and arterial hypertension (OR = 4.59, CI = 1.46–14.49, P = 0.009) as independent risk factors for de novo MetS. MetS incidence correlated with steroid dosage after OLT (5.2 ± 2.4 mg/day vs. 7.1 ± 4.7 mg/day, P = 0.014), and was linked to NAFLD (P = 0.001) via obesity (OR = 4.67, CI = 1.55–14.1, P = 0.006) and dyslipidemia (OR = 4.23, CI = 1.35–13.3, P = 0.013) post‐OLT. In conclusion, we were able to identify low threshold HbA1c as a novel risk factor for MetS after OLT and described a link of MetS with NAFLD in transplant organs. This study also indicated that steroid treatment is associated with MetS rates after OLT. 相似文献
93.
Daniel S. Engeler Andrew P. Baranowski Paulo Dinis-Oliveira Suzy Elneil John Hughes Embert J. Messelink Arndt van Ophoven Amanda C. Williams 《European urology》2013
Context
Progress in the science of pain has led pain specialists to move away from an organ-centred understanding of pain located in the pelvis to an understanding based on the mechanism of pain and integrating, as far as possible, psychological, social, and sexual dimensions of the problem. This change is reflected in all areas, from taxonomy through treatment. However, deciding what is adequate investigation to rule out treatable disease before moving to this way of engaging with the patient experiencing pain is a complex process, informed by pain expertise as much as by organ-based medical knowledge.Objective
To summarise the evolving changes in the management of patients with chronic pelvic pain by referring to the 2012 version of the European Association of Urology (EAU) guidelines on chronic pelvic pain.Evidence acquisition
The working panel highlights some of the most important aspects of the management of patients with chronic pelvic pain emerging in recent years in the context of the EAU guidelines on chronic pelvic pain. The guidelines were completely updated in 2012 based on a systematic review of the literature from online databases from 1995 to 2011. According to this review, levels of evidence and grades of recommendation were added to the text. A full version of the guidelines is available at the EAU office or Web site (www.uroweb.org).Evidence synthesis
The previously mentioned issues are explored in this paper, which refers throughout to dilemmas for the physician and treatment team as well as to the need to inform and engage the patient in a collaborative empirical approach to pain relief and rehabilitation. These issues are exemplified in two case histories.Conclusions
Chronic pelvic pain persisting after appropriate treatment requires a different approach focussing on pain. This approach integrates the medical, psychosocial, and sexual elements of care to engage the patient in a collaborative journey towards self-management. 相似文献94.
95.
Tobias Böttcher Arndt Rolfs Bianca Meyer Annette Grossmann Daniela Berg Peter Kropp Reiner Benecke Uwe Walter 《Journal of neurology》2013,260(10):2523-2531
Homozygous or compound heterozygous mutations in the glucocerebrosidase gene cause Gaucher disease. Moreover, heterozygous glucocerebrosidase gene mutations represent the most common genetic risk factor for Parkinson’s disease (PD) known so far. Substantia nigra (SN) hyperechogenicity, a sonographic feature thought to reflect iron accumulation, has been described in both PD and Gaucher disease patients. Here we studied how clinical, genetic, and brain sonographic findings relate to the occurrence of PD in Gaucher disease. Sixteen Gaucher disease patients, 12 PD patients, and 32 control subjects were enrolled. The glucocerebrosidase genotypes were identified by DNA sequencing. All subjects underwent transcranial ultrasound, and eight Gaucher disease patients additionally MRI for comparison with SN ultrasound findings. SN hyperechogenicity and reduced echogenicity of brainstem raphe were more frequent in Gaucher disease patients (62, 37 %) than in controls (12, 12 %; p < 0.001, p < 0.05). SN hyperechogenicity in Gaucher disease patients was unrelated to type or severity of glucocerebrosidase gene mutation, but correlated with iron-sensitive MRI-T2 hypointensity of SN pars compacta, and with age at start of enzyme replacement therapy. While none of the five Gaucher disease patients with signs of PD (definite PD, n = 4; early PD, n = 1) had severe glucocerebrosidase gene mutations known to cause neuronopathic Gaucher disease, all carried a N370S allele, previously reported to predict non-neuronopathic Gaucher disease. Hyposmia, higher non-motor symptoms score (constipation, depression, executive dysfunction), and SN hyperechogenicity were characteristic features of Gaucher disease-related PD. We conclude that the combined clinical, genetic, and transcranial sonographic assessment may improve the PD risk evaluation in Gaucher disease. 相似文献
96.
目的分析先天性肠闭锁病例的诊断及治疗,以提高治愈率及术后生活质量。方法回顾性分析166例先天性肠闭锁的临床资料。结果治愈142例,治愈率85.5%(142/166),其中包括18例二期手术治愈者;术中10例、术后8例放弃治疗;术后死亡6例。结论早期诊断和选择合理的术式是提高肠闭锁治愈率的关键,基础支持及手术技术改进能促进病情的恢复,改善预后。 相似文献
97.
Alexandra Masson-Lecomte Marta Rava Francisco X. Real Arndt Hartmann Yves Allory Núria Malats 《European urology》2014
Context
Host immune response has an impact on tumour development and progression. There is interest in the use of inflammatory biomarkers (InfBMs) in cancer care. Although several studies assessing the potential prognostic value of InfBMs in cancer have been published in the past decades, they have had no impact on the management of patients with urothelial bladder carcinoma (UBC).Objective
To review and summarise the scientific literature on the prognostic value of tumour, serum, urine, and germline DNA InfBMs on UBC.Evidence acquisition
A systematic review of the literature was performed searching the Medline and Embase databases for original articles published between January 1975 and November 2013. The main inclusion criterion was the provision of a survival analysis (Kaplan-Meier and/or Cox) according to the Reporting Recommendations for Tumor Marker Prognostic Studies guidelines for the assessment of prognostic markers. We focused on markers assessed at least twice in the literature. Findings are reported following Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines.Evidence synthesis
Overall, 34 publications, mostly retrospective, fulfilled the main inclusion criterion. Main limitations of these studies were missing relevant information about design or analysis and heterogeneous methodology used. Inflammatory cells, costimulatory molecules in tumour cells, and serum cytokines showed prognostic significance, mainly in univariable analyses. High C-reactive protein values were consistently reported as an independent prognostic factor for mortality in invasive UBC.Conclusions
There is a dearth of studies on InfBMs in UBC compared with other tumour types. Evidence suggests that InfBMs may have an impact on the management of patients with UBC. Currently, methodological drawbacks of the studies limit the translational potential of results.Patient summary
In this review, we analysed studies evaluating the impact of inflammatory response on bladder cancer progression. Despite methodological limitations, some inflammatory biomarkers should be further analysed because they hold promise to improve patient care. 相似文献98.
Michael Froehner Rainer Koch Arndt Lossnitzer Rebecca R. Schober Markus Schuler Manfred P. Wirth 《World journal of urology》2014,32(2):445-451
Purpose
Inguinoscrotal sarcomas are exceedingly rare tumors. The aim of this study was to enable clinicians an easy and rapid access to the available information on this tumor entity.Methods
An updated series of 21 men treated for sarcoma of the inguinoscrotal region at our institution between 1992 and 2012 was analyzed, and a systematic review of the literature with meta-analysis of outcome data was performed. The review was focused on demographic data, survival rates, prognostic factors, sites of relapse and complete remissions or successful treatments for metastatic disease.Results
With only 38 %, the proportion of high-grade tumors in our sample was lower than reported in the literature and the 10-year relapse-free, disease-specific and overall survival rates were favorable with 77, 93 and 81 %. Beside our series, twelve studies including 345 patients were identified in the literature. The weighed mean 10-year relapse-free, disease-specific and overall survival rates were 63, 64 and 50 %. Only in patients with rhabdomyosarcoma, durable control of metastatic disease has been reported in more than one case (n = 4). Successful treatment in these cases consisted of a combination of complete surgical resection of metastatic lesions, subsequent chemotherapy and (optional) radiotherapy.Conclusions
Overall, about two-thirds of inguinoscrotal sarcomas may be cured. In series with a predominance of low-grade tumors, the long-term survival rates in completely excised inguinoscrotal sarcomas may be as favorable as in testicular germ cell tumors. Life-long surveillance is advisable to detect late recurrences. 相似文献99.
100.
Connor J. Wakefield Fadi Hamati Justin M. Karush Andrew T. Arndt Nicole Geissen Michael J. Liptay Jeffrey A. Borgia Sanjib Basu Christopher W. Seder 《Journal of thoracic disease》2021,13(2):861
BackgroundThe impact of sarcopenia on the outcome of esophageal cancer patients remains unknown in North American populations. The current study aims to investigate if sarcopenia at the time of esophagectomy for locally-advanced esophageal cancer (LAEC) is associated with survival.MethodsPatients who underwent induction therapy followed by esophagectomy for LAEC between 2010–2018 at a single institution were identified. Exclusion criteria included follow-up less than 90 days and distant metastatic disease at the time of surgery. Demographic, treatment, and outcome data were retrospectively collected. Computed tomography (CT) scans following induction therapy were analyzed to calculate skeletal muscle index (SMI). Overall survival (OS) and disease-free survival (DFS) were examined using Kaplan-Meier and Cox Proportional Hazard regression analysis.ResultsOverall, 52 patients met inclusion criteria with a median BMI of 25 (IQR, 22.4–29.1) kg/m2 and age of 65 (IQR, 57–70) years. Sarcopenia was present in 75% (39/52) of patients at the time of surgery. Sarcopenic patients had a lower median BMI and higher median age when compared to non-sarcopenic patients. There was no difference in gender, race, stage, operative technique, post-operative complications, or hospital length of stay between sarcopenic and non-sarcopenic patients. With a median follow-up of 24.9 months, patients with sarcopenia at the time of esophagectomy had worse OS [median 24.3 (IQR, 9.9–34.5) vs. 50.9 (IQR, 25.6–50.9) months, P=0.0292] and DFS [median 11.7 (IQR, 6.4–25.8) vs. 29.4 (IQR, 12.8–26.7) months, P=0.0387] compared to non-sarcopenic patients.ConclusionsSarcopenia is associated with reduced overall and DFS in patients undergoing esophagectomy for LAEC. 相似文献